Risk factors for treatment interruption and severe adverse effects to benznidazole in adult patients with Chagas disease

BACKGROUND: Etiological treatment of Chagas disease in chronic asymptomatic patients is still in debate and the adverse effects of traditional drugs are one of the main concerns in clinical practice. This study evaluated retrospectively the safety profile of benznidazole (BZN) and identified predict...

Descripción completa

Detalles Bibliográficos
Autores principales: Olivera, Mario J., Cucunubá, Zulma M., Valencia-Hernández, Carlos A., Herazo, Rafael, Agreda-Rudenko, Diana, Flórez, Carolina, Duque, Sofía, Nicholls, Rubén S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614433/
https://www.ncbi.nlm.nih.gov/pubmed/28949997
http://dx.doi.org/10.1371/journal.pone.0185033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614433/
https://www.ncbi.nlm.nih.gov/pubmed/28949997
http://dx.doi.org/10.1371/journal.pone.0185033

Ejemplares similares